Chemical Evaluation of the Effects of Storage Conditions on the Botanical Goldenseal Using Marker-based and Metabolomics Approaches

Overview

Journal Yale J Biol Med

Specialty Biology

Date 2020 Jul 2

PMID 32607087

Authors

Manead Khin

Nadja B Cech

Joshua J Kellogg

Lindsay K Caesar

Affiliations

Soon will be listed here.

Abstract

commonly known as goldenseal, is a botanical native to the southeastern United States that has been used for the treatment of infection. The activity of goldenseal is often attributed to the presence of alkaloids (cyclic, nitrogen-containing compounds) present within its roots. Chemical components of botanical supplements like goldenseal may face degradation if not stored properly. The purpose of the research was to analyze the stability of known and unknown metabolites of during exposure to different storage conditions using mass spectrometry. Three abundant metabolites of , berberine, canadine, and hydrastine, were chosen for targeted analysis, and the stability of unknown metabolites was evaluated using untargeted metabolomics. The analysis and evaluation of samples were performed utilizing LC-MS and Principal Component Analysis (PCA). The research project focused on identifying the chemical changes in the metabolite content of under different temperature conditions (40°C ± 5°C, 20°C ± 5°C , and 4°C ± 5°C), different light:dark (hr:hr) cycles (16:8, 12:12, and 0:24), and different sample conditions (powdered roots versus whole roots) over a six month period. The results of this 6-month study revealed that the storage conditions evaluated had no significant effects on the chemical composition of roots. Hence, as long as roots are stored within the storage conditions tested in the study, no significant changes in chemical compositions of metabolites are expected.

References

Newman D, Cragg G . Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016; 79(3):629-61. DOI: 10.1021/acs.jnatprod.5b01055. View

Shyur L, Yang N . Metabolomics for phytomedicine research and drug development. Curr Opin Chem Biol. 2008; 12(1):66-71. DOI: 10.1016/j.cbpa.2008.01.032. View

Scazzocchio F, Cometa M, Tomassini L, Palmery M . Antibacterial activity of Hydrastis canadensis extract and its major isolated alkaloids. Planta Med. 2001; 67(6):561-4. DOI: 10.1055/s-2001-16493. View

KHOSLA P, Neeraj V, Gupta S, Satpathy G . Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique. 1992; 69:147-65. View

. Toxicology and carcinogenesis studies of goldenseal root powder (Hydrastis Canadensis) in F344/N rats and B6C3F1 mice (feed studies). Natl Toxicol Program Tech Rep Ser. 2011; (562):1-188. View

Rajalahti T, Kvalheim O . Multivariate data analysis in pharmaceutics: a tutorial review. Int J Pharm. 2011; 417(1-2):280-90. DOI: 10.1016/j.ijpharm.2011.02.019. View

Le P, McCooeye M, Windust A . Application of UPLC-QTOF-MS in MS(E) mode for the rapid and precise identification of alkaloids in goldenseal (Hydrastis canadensis). Anal Bioanal Chem. 2014; 406(6):1739-49. DOI: 10.1007/s00216-013-7558-x. View

Dettmer K, Aronov P, Hammock B . Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2006; 26(1):51-78. PMC: 1904337. DOI: 10.1002/mas.20108. View

Kellogg J, Paine M, McCune J, Oberlies N, Cech N . Selection and characterization of botanical natural products for research studies: a NaPDI center recommended approach. Nat Prod Rep. 2019; 36(8):1196-1221. PMC: 6658353. DOI: 10.1039/c8np00065d. View

10.

Leyte-Lugo M, Britton E, Foil D, Brown A, Todd D, Rivera-Chavez J . Secondary Metabolites from the Leaves of the Medicinal Plant Goldenseal (). Phytochem Lett. 2017; 20:54-60. PMC: 5516942. DOI: 10.1016/j.phytol.2017.03.012. View

11.

Hwang B, Roberts S, Chadwick L, Wu C, Kinghorn A . Antimicrobial constituents from goldenseal (the Rhizomes of Hydrastis canadensis) against selected oral pathogens. Planta Med. 2003; 69(7):623-7. DOI: 10.1055/s-2003-41115. View

12.

Cicero A, Baggioni A . Berberine and Its Role in Chronic Disease. Adv Exp Med Biol. 2016; 928:27-45. DOI: 10.1007/978-3-319-41334-1_2. View

13.

Karmakar S, Biswas S, Khuda-Bukhsh A . Anti-carcinogenic potentials of a plant extract (Hydrastis canadensis): I. Evidence from in vivo studies in mice (Mus musculus). Asian Pac J Cancer Prev. 2010; 11(2):545-51. View

14.

Caesar L, Kellogg J, Kvalheim O, Cech N . Opportunities and Limitations for Untargeted Mass Spectrometry Metabolomics to Identify Biologically Active Constituents in Complex Natural Product Mixtures. J Nat Prod. 2019; 82(3):469-484. PMC: 6837904. DOI: 10.1021/acs.jnatprod.9b00176. View

15.

Wallace E, Oberlies N, Cech N, Kellogg J . Detection of adulteration in Hydrastis canadensis (goldenseal) dietary supplements via untargeted mass spectrometry-based metabolomics. Food Chem Toxicol. 2018; 120:439-447. PMC: 6434943. DOI: 10.1016/j.fct.2018.07.033. View

16.

Borchers A, Keen C, Stern J, Gershwin M . Inflammation and Native American medicine: the role of botanicals. Am J Clin Nutr. 2000; 72(2):339-47. DOI: 10.1093/ajcn/72.2.339. View

17.

Britton E, Kellogg J, Kvalheim O, Cech N . Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal). J Nat Prod. 2017; 81(3):484-493. PMC: 6251718. DOI: 10.1021/acs.jnatprod.7b00654. View

18.

Mahady G, Pendland S, Stoia A, Chadwick L . In vitro susceptibility of Helicobacter pylori to isoquinoline alkaloids from Sanguinaria canadensis and Hydrastis canadensis. Phytother Res. 2003; 17(3):217-21. DOI: 10.1002/ptr.1108. View

19.

Le P, McCooeye M, Windust A . Characterization of the alkaloids in goldenseal (Hydrastis canadensis) root by high resolution Orbitrap LC-MS(n). Anal Bioanal Chem. 2012; 405(13):4487-98. DOI: 10.1007/s00216-012-6539-9. View

20.

Okada T, Nakamura Y, Kanaya S, Takano A, Malla K, Nakane T . Metabolome analysis of Ephedra plants with different contents of ephedrine alkaloids by using UPLC-Q-TOF-MS. Planta Med. 2009; 75(12):1356-62. DOI: 10.1055/s-0029-1185577. View